Topic
daraxonrasib
3 stories about daraxonrasib that passed the news check, newest first.
Research ·
'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment
The first-in-class RAS inhibitor daraxonrasib (Rasonque), combined with chemotherapy, showed promise as a first-line treatment for metastatic pancreatic adenocarcinoma (PDAC).
MedPageToday.com - medical news for physicians
Research ·
Erasca data add to pressure facing Revolution’s breakthrough cancer drug
Erasca reported data on its KRAS-targeted drug in pancreatic cancer, adding pressure on Revolution Medicines' drug Rasonque, according to BioPharma Dive.
BioPharma Dive - Latest News · 2 sources
Research ·
expert reaction to abstract about Daraxonrasib plus GnP for metastatic pancreatic adenocarcinoma
An abstract presented at EORTC-NCI-AACR 2026 reports on daraxonrasib plus GnP for metastatic pancreatic adenocarcinoma.
Science Media Centre